Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Boehringer Ingelheim
USWM, LLC (dba US WorldMeds)
Pfizer
Conjupro Biotherapeutics, Inc.
Pfizer
EpiBiologics
Pfizer
Dragonfly Therapeutics
Aktis Oncology, Inc.
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
ALX Oncology Inc.
IDEAYA Biosciences
Adaptimmune
Boehringer Ingelheim
Immunolight, LLC
SN BioScience
Cue Biopharma
Oscotec Inc.
VLP Therapeutics
Boehringer Ingelheim
Novartis
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
EMD Serono
Sichuan Baili Pharmaceutical Co., Ltd.
MeiraGTx UK II Ltd
Memgen, Inc.
Genexine, Inc.
Exelixis
Bicara Therapeutics
MacroGenics
Incyte Corporation
Genentech, Inc.
Celldex Therapeutics
DEKA Biosciences
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
BeiGene
Carisma Therapeutics Inc
Jacobio Pharmaceuticals Co., Ltd.
Acepodia Biotech, Inc.
Inhibrx Biosciences, Inc
IntraGel Therapeutics
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Taiho Pharmaceutical Co., Ltd.
BlueSky Immunotherapies GmbH